NCT04698330 - Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Type 1 Diabetes MellitusAutoimmune Diabetes

Interventions

DRUG

Berberine

0.6g (6 pills) of Berberine tablets administered twice a day orally before meal for 3 months

DRUG

Inulin

0.6g (6 pills) of Inulin tablets administered twice a day orally before meal for 3 months

DRUG

Berberine placebo tablets

0.6g (6 pills) of Berberine placebo tablets administered twice a day orally before meal for 3 months

DRUG

Inulin placebo tablets

0.6g (6 pills) of Inulin placebo tablets administered twice a day orally before meal for 3 months

Trial Locations (1)

Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, Changsha

All Listed Sponsors

lead

Second Xiangya Hospital of Central South University

OTHER